Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Enhabit, Inc.
Enhabit, Inc. News
Enhabit, Inc. Quantitative Score

About Enhabit, Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Enhabit, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Enhabit, Inc. Financials
Table Compare
Compare EHAB metrics with: | |||
---|---|---|---|
Earnings & Growth | EHAB | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | EHAB | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | EHAB | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | EHAB | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Enhabit, Inc. Income
Enhabit, Inc. Balance Sheet
Enhabit, Inc. Cash Flow
Enhabit, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Strong Sell |
Return on Assets | Strong Sell |
Debt/Equity Ratio | Buy |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Enhabit, Inc. Executives
Name | Role |
---|---|
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. | President, Chief Executive Officer & Director |
Ms. Julie Diane Jolley B.S.N., R.N. | Executive Vice President of Home Health |
Ms. Tanya R. Marion | Chief Human Resources Officer |
Mr. Dylan C. Black | General Counsel & Secretary |
Mr. Ryan T. Solomon | Chief Financial Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. | President, Chief Executive Officer & Director | Female | 1966 | 1.08M |
Ms. Julie Diane Jolley B.S.N., R.N. | Executive Vice President of Home Health | Female | 1973 | 460.84K |
Ms. Tanya R. Marion | Chief Human Resources Officer | Female | 1974 | 413.84K |
Mr. Dylan C. Black | General Counsel & Secretary | Male | 1969 | 411.25K |
Mr. Ryan T. Solomon | Chief Financial Officer | Male | 1980 | 326.52K |
Enhabit, Inc. Insider Trades
Date | 10 Apr |
Name | Bolton Jeffrey |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 4670 |
Date | 10 Apr |
Name | Hoeflinger Erin |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 2958 |
Date | 10 Apr |
Name | Rush Gregory S |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 3113 |
Date | 10 Apr |
Name | ELSON CHARLES M |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 2335 |
Date | 10 Apr |
Name | MCGUIGAN STUART M |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 2335 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
10 Apr | Bolton Jeffrey | Director | Acquired | A-Award | 4670 |
10 Apr | Hoeflinger Erin | Director | Acquired | A-Award | 2958 |
10 Apr | Rush Gregory S | Director | Acquired | A-Award | 3113 |
10 Apr | ELSON CHARLES M | Director | Acquired | A-Award | 2335 |
10 Apr | MCGUIGAN STUART M | Director | Acquired | A-Award | 2335 |